AI In Drug Discovery: From Protein Structures to Molecular Interactions Artificial intelligence is reshaping drug discovery, moving well beyond predicting static protein structures to modeling the intricate dance of biomolecular interactions. This leap is enabling scienti... AI drug discovery AlphaFold biopharma innovation biotechnology computational biology machine learning protein interactions therapeutic design
MIT Researchers Chart New Paths for Alzheimer’s Drug Targets Beyond Amyloid Alzheimer’s disease has challenged the scientific community for decades, especially as treatments focused on amyloid plaques have not delivered the hoped-for results. In a promising shift, researchers... Alzheimer's computational biology DNA repair drug discovery genetics MIT neurodegeneration RNA modification
New Genetic Pathways Offer Hope for Alzheimer’s Drug Development Alzheimer’s disease is a condition that affects millions globally and has traditionally been linked to amyloid plaques in the brain. Most drug development efforts have targeted these plaques but real-... Alzheimer's computational biology DNA repair drug discovery genetics neurodegeneration RNA modification